CTNNB1 and hepatocellular carcinoma: In three patients with unresectable HCC with high intensity in the hepatobiliary phase of EOB-MRI, CTNNB1 alterations in cfDNA were observed in two patients (66.7%, 2/3), while all four patients without HCC with iso-high intensity in the hepatobiliary phase of EOB-MRI lacked mutations.